ANTICOAGULANTS

Per page:
Sort products:
ELIQUIS APIXABAN 2.5MG 60TABS
In stock

$235.90 USD

ELIQUIS APIXABAN 2.5MG 60TABS
ELIQUIS APIXABAN 5MG 60TABS
In stock

$235.90 USD

ELIQUIS APIXABAN 5MG 60TABS
INHEPAR VIAL HEPARIN 1000 UNITS/ML 10ML
In stock

$24.40 USD

INHEPAR VIAL HEPARIN 1000 UNITS/ML 10ML
INHEPAR VIAL HEPARIN 5000 UNITS/ML 10ML
In stock

$48.37 USD

INHEPAR VIAL HEPARIN 5000 UNITS/ML 10ML
INHEPAR VIAL HEPARIN 5000 UNITS/ML 5ML
In stock

$32.96 USD

INHEPAR VIAL HEPARIN 5000 UNITS/ML 5ML
PRADAXA DABIGATRAN 110MG 60CAPS
In stock

$269.67 USD

PRADAXA DABIGATRAN 110MG 60CAPS
PRADAXA DABIGATRAN 150MG 60CAPS
In stock

$269.67 USD

PRADAXA DABIGATRAN 150MG 60CAPS
PRADAXA DABIGATRAN 75MG 60CAPS
In stock

$269.67 USD

PRADAXA DABIGATRAN 75MG 60CAPS
XARELTO RIVAROXABAN 10MG 30TABS
In stock

$286.14 USD

XARELTO RIVAROXABAN 10MG 30TABS
XARELTO RIVAROXABAN 15MG 28TABS
In stock

$317.52 USD

XARELTO RIVAROXABAN 15MG 28TABS
XARELTO RIVAROXABAN 2.5MG 28TABS
In stock

$153.08 USD

XARELTO RIVAROXABAN 2.5MG 28TABS
XARELTO RIVAROXABAN 20MG 14TABS
In stock

$152.96 USD

XARELTO RIVAROXABAN 20MG 14TABS
ANTICOAGULANTS
Anticoagulants, commonly known as blood thinners, are chemical substances that prevent or reduce coagulation of blood, prolonging the clotting time.Some of them occur naturally in blood-eating animals such as leeches and mosquitoes, where they help keep the bite area unclotted long enough for the animal to obtain some blood. As a class of medications, anticoagulants are used in therapy for thrombotic disorders. Oral anticoagulants (OACs) are taken by many people in pill or tablet form, and various intravenous anticoagulant dosage forms are used in hospitals. Some anticoagulants are used in medical equipment, such as sample tubes, blood transfusion bags, heart-lung machines, and dialysis equipment. One of the first anticoagulants, warfarin, was initially approved as a rodenticide.
 
Anticoagulants are closely related to antiplatelet drugs and thrombolytic drugs by manipulating the various pathways of blood coagulation. Specifically, antiplatelet drugs inhibit platelet aggregation (clumping together), whereas anticoagulants inhibit specific pathways of the coagulation cascade, which happens after the initial platelet aggregation and ultimately leads to formation of fibrin and stable aggregated platelet products.